The U.S. FDA has approved SELARSDI™ (ustekinumab-aekn) as interchangeable with the reference biologic Stelara® (ustekinumab) ...

On the FDA’s docket this month are two expansion bids, one for GSK’s asthma drug Nucala into COPD and another for Merck’s ...

The U.S. Food and Drug Administration (FDA) has approved prademagene zamikeracel (Zevaskyn) for the treatment of blistering ...

Research and development expenses for the first quarter of 2025 were $42.9 million versus $20.7 million for the comparable ...

Using lasers, doctors can alter cornea pigments. The FDA doesn't regulate this growing practice — is it worth it?

In the Phase 2 open-label study, REC-4881 (4 mg QD) led to a median 43% reduction (n=6 patients) in polyp burden at the Week ...

The Medicare drug price negotiation provision in the 2022 Inflation Reduction Act treats small molecule drugs and biological products differently.

Discover why Mirum Pharmaceuticals is a growth opportunity with billion-dollar pipeline potentials, near-term catalysts, and ...

Fast Track Designation highlights potential of ATH434 to address high unmet need for individuals with MSA - MELBOURNE, Australia and SAN FRANCISCO, May 05, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeuti ...

Some packages of tomatoes that were sold in several states, including Ohio, have been recalled due to a possible salmonella ...

Some packages of tomatoes that were sold in several states, including Ohio, have been recalled due to a possible salmonella ...